Deka Bank Deutsche Girozentrale Incyte Corp Transaction History

Deka Bank Deutsche Girozentrale

$53.9 Billion
Q3 2024

A detailed history of Deka Bank Deutsche Girozentrale transactions in Incyte Corp stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 160,078 shares of INCY stock, worth $11 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

160,078

Previous 128,217 24.85%

Holding current value

$11 Million

Previous $7.87 Million 33.3%

% of portfolio

0.02%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$57.33 - $68.61 $1.83 Million - $2.19 Million	31,861 Added 24.85%	160,078 $10.5 Million
Q2 2024 Aug 08, 2024	SELL	$51.18 - $63.75 $1.24 Million - $1.54 Million	-24,235 Reduced 15.9%	128,217 $7.87 Million
Q1 2024 Apr 24, 2024	BUY	$56.55 - $66.59 $1.38 Million - $1.62 Million	24,328 Added 18.99%	152,452 $8.65 Million
Q4 2023 Jan 24, 2024	SELL	$52.16 - $64.19 $135,042 - $166,187	-2,589 Reduced 1.98%	128,124 $8.02 Million
Q3 2023 Nov 13, 2023	BUY	$57.77 - $65.93 $281,744 - $321,540	4,877 Added 3.88%	130,713 $7.65 Million
Q2 2023 Jul 25, 2023	BUY	$60.95 - $75.51 $52,904 - $65,542	868 Added 0.69%	125,836 $7.78 Million
Q1 2023 Apr 24, 2023	SELL	$70.23 - $86.01 $4.97 Million - $6.09 Million	-70,761 Reduced 36.15%	124,968 $8.82 Million
Q4 2022 Feb 01, 2023	SELL	$67.18 - $84.11 $291,561 - $365,037	-4,340 Reduced 2.17%	195,729 $15.5 Million
Q3 2022 Nov 02, 2022	BUY	$66.18 - $82.86 $380,071 - $475,864	5,743 Added 2.96%	200,069 $13.2 Million
Q2 2022 Aug 03, 2022	BUY	$66.18 - $83.18 $2.14 Million - $2.68 Million	32,274 Added 19.92%	194,326 $14.7 Million
Q1 2022 Apr 28, 2022	SELL	$66.02 - $79.71 $214,300 - $258,738	-3,246 Reduced 1.96%	162,052 $13 Million
Q4 2021 Feb 02, 2022	BUY	$63.34 - $74.11 $2.3 Million - $2.7 Million	36,381 Added 28.22%	165,298 $12.2 Million
Q3 2021 Oct 22, 2021	BUY	$68.67 - $84.02 $3.11 Million - $3.81 Million	45,346 Added 54.26%	128,917 $8.88 Million
Q2 2021 Aug 05, 2021	BUY	$79.87 - $87.53 $58,704 - $64,334	735 Added 0.89%	83,571 $7.04 Million
Q1 2021 Apr 28, 2021	BUY	$76.02 - $100.5 $153,332 - $202,708	2,017 Added 2.5%	82,836 $6.64 Million
Q4 2020 Mar 12, 2021	SELL	$80.74 - $97.7 $443,747 - $536,959	-5,496 Reduced 6.37%	80,819 $6.97 Million
Q3 2020 Oct 29, 2020	BUY	$85.07 - $109.69 $4.4 Million - $5.67 Million	51,716 Added 149.47%	86,315 $7.55 Million
Q2 2020 Aug 04, 2020	SELL	$74.18 - $108.93 $999,649 - $1.47 Million	-13,476 Reduced 28.03%	34,599 $3.56 Million
Q1 2020 May 14, 2020	SELL	$63.18 - $85.97 $860,132 - $1.17 Million	-13,614 Reduced 22.07%	48,075 $3.49 Million
Q4 2019 Feb 04, 2020	SELL	$73.04 - $95.72 $6.23 Million - $8.17 Million	-85,332 Reduced 58.04%	61,689 $5.45 Million
Q3 2019 Nov 14, 2019	SELL	$72.82 - $86.52 $4.72 Million - $5.61 Million	-64,837 Reduced 30.6%	147,021 $10.8 Million
Q2 2019 Aug 01, 2019	BUY	$73.52 - $88.7 $7.37 Million - $8.89 Million	100,195 Added 89.73%	211,858 $18 Million
Q1 2019 May 10, 2019	BUY	$63.56 - $88.17 $74,365 - $103,158	1,170 Added 1.06%	111,663 $8.28 Million
Q4 2018 Feb 12, 2019	SELL	$58.5 - $69.94 $68,445 - $81,829	-1,170 Reduced 1.05%	110,493 $6.93 Million
Q3 2018 Nov 09, 2018	SELL	$61.75 - $74.23 $73,235 - $88,036	-1,186 Reduced 1.05%	111,663 $0
Q2 2018 Aug 14, 2018	SELL	$60.85 - $83.98 $3.26 Million - $4.5 Million	-53,558 Reduced 32.18%	112,849 $7.47 Million
Q1 2018 May 03, 2018	BUY	$83.06 - $100.98 $4.24 Million - $5.16 Million	51,068 Added 44.28%	166,407 $14.2 Million
Q3 2017 Nov 06, 2017	BUY	$109.15 - $138.27 $12.6 Million - $15.9 Million	115,339	115,339 $14.4 Million

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.3B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Account

Deka Bank Deutsche Girozentrale Incyte Corp Transaction History